Procopio (San Diego) is pleased to announce the addition of partner Robert (Bob) Ramos to the firm’s recently expanded Life Sciences practice group.[caption id="attachment_3604" align="alignleft" width="150"] Robert Ramos[/caption]Mr. Ramos has over 20 years of Life Sciences intellectual property experience in both private practice and the biotechnology industry related to worldwide patent and trademark acquisition and strategic counseling.  He has assisted venture-backed startups, mid-sized companies, basic research institutes, as well as large biopharmaceutical companies in need of extensive portfolio management in the biotechnology arts, including molecular biology, modern genomics for personalized medicine, antibodies, cancer therapies, gene therapy and cellular immunotherapy.Mr. Ramos conducted his graduate work in biology at UCSD, with an emphasis on molecular genetics, where he constructed genetically engineered viruses for potential use in gene therapy.  Prior to joining the firm, he practiced at Amgen for over 10 years where he was the lead IP Attorney for two commercial and two Phase I biologics, among other assets.“We enthusiastically welcome Robert to the firm,” said Tom Turner, Procopio’s Managing Partner. “The combination of his background  in molecular biology with his keen understanding of the unique challenges faced by companies in the Life Sciences sector is truly an invaluable asset to our clients.”Procopio's Life Sciences group has decades of experience serving biotechnology and molecular biology clients, providing counsel on matters involving intellectual property, financing, licensing, facilities and mergers and acquisitions.